{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:51:04Z","timestamp":1794718264802,"version":"4.9.1"},"reference-count":13,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2008,9,24]],"date-time":"2008-09-24T00:00:00Z","timestamp":1222214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Paediatrics Child Health"],"published-print":{"date-parts":[[2008,10]]},"abstract":"<jats:title>Abstract:<\/jats:title><jats:p>An 11 year old boy developed acute agitation and suicidal ideation after commencing atomoxetine shortly after it was approved for use in Australia. The clinical features were similar to reactions described in response to selective serotonin reuptake inhibitors. The case highlights the importance of close monitoring when starting newly registered medications. An increased risk of suicidal thinking was subsequently identified for this drug leading to a Food and Drug Administration alert and a boxed warning in September 2005, however there are still no other published case reports of acute suicidality.<\/jats:p>","DOI":"10.1111\/j.1440-1754.2008.01389.x","type":"journal-article","created":{"date-parts":[[2008,9,25]],"date-time":"2008-09-25T01:48:36Z","timestamp":1222307316000},"page":"596-598","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Acute suicidality after commencing atomoxetine"],"prefix":"10.1111","volume":"44","author":[{"given":"Georgia Armat","family":"Paxton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel Edward","family":"Cranswick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,9,24]]},"reference":[{"key":"e_1_2_3_2_2","volume-title":"Strattera. Atomoxetine Hydrochloride Product Information. MIMS Annual","author":"Caswell A","year":"2004"},{"key":"e_1_2_3_3_2","unstructured":"Eli Lilly and Company.Strattera TM (Atomoxetine HCl). Attachment to FDA approval letter for NDA 21\u2010411.Eli Lilly and Company 2002. Available from:http:\/\/www.fda.gov\/cder\/foi\/label\/2002\/21411_strattera_lbl.pdf[accessed 24 November 2004."},{"key":"e_1_2_3_4_2","first-page":"4","article-title":"Warning on Strattera for attention\u2010deficit hyperactivity disorder","volume":"39","year":"2005","journal-title":"FDA Consumer"},{"key":"e_1_2_3_5_2","first-page":"1447","article-title":"Suicidal ideation among children taking atomoxetine (Strattera)","volume":"173","author":"Wooltorton E","year":"2005","journal-title":"CMAJ"},{"key":"e_1_2_3_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000139760.11458.aa"},{"key":"e_1_2_3_7_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.142.12.1517"},{"key":"e_1_2_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2005.12.024"},{"key":"e_1_2_3_9_2","doi-asserted-by":"publisher","DOI":"10.1080\/15563650600584311"},{"key":"e_1_2_3_10_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-2999"},{"key":"e_1_2_3_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"e_1_2_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16043-1"},{"key":"e_1_2_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2007.06.002"},{"key":"e_1_2_3_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000246056.83791.b6"}],"container-title":["Journal of Paediatrics and Child Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1754.2008.01389.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1754.2008.01389.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T17:59:05Z","timestamp":1696874345000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1754.2008.01389.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,24]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["10.1111\/j.1440-1754.2008.01389.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1754.2008.01389.x","archive":["Portico"],"relation":{},"ISSN":["1034-4810","1440-1754"],"issn-type":[{"value":"1034-4810","type":"print"},{"value":"1440-1754","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,24]]},"assertion":[{"value":"2008-09-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}